Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Cameli (Siena(FI), Italy), S. Gonnelli (Siena(FI), Italy), E. Bargagli (Siena(FI), Italy), M. D'Alessandro (Siena(FI), Italy), L. Bergantini (Siena(FI), Italy), D. Tomai Pitinca (Siena(FI), Italy), R. Refini (Siena(FI), Italy), M. Pieroni (Siena(FI), Italy), P. Sestini (Siena(FI), Italy), C. Caffarelli (Siena(FI), Italy). The value of urinary calcium as biomarker in chronic sarcoidosis. 1089

Member's Comments

No comment yet.

Related content which might interest you: Changes in urinary biomarkers between stable state and exacerbation of COPD Source: International Congress 2018 – Biomarkers of COPD Year: 2018 The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 Clinical validity of blood and urinary desmosine as biomarkers for chronic obstructive pulmonary disease Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Prognostic significance of serum markers in acute exacerbation of idiopathic interstitial pneumonias Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Evaluation of prostaglandin-E-main urinary metabolite (PGE-MUM) in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 573s Year: 2007 The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007 Association between airway bacterial abundance and urinary inflammatory biomarkers in COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Serum immunoglobulin level is a useful marker for the risk of opportunistic infection in steroid dependent patients with chronic inflammatory airway diseases Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Nitrogen multiple breath washout indices as potentially prognostic markers in idiopathic pulmonary fibrosis Source: International Congress 2017 – Lung function testing Year: 2017 The importance value of persistance hypercalciuria in sarcoidosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 331s Year: 2005 Correlation of HRCT proven inflammatory changes with serum levels of ACE, sIL-2r and calciuria in pulmonary sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 226s Year: 2003 Serum magnesium levels of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Is chronic obstructive pulmonary disease a risk factor for the development of lower urinary tract symptoms? Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006 The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Prognostic value of induced sputum level of total lipid phosphorus in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 Calcium and magnesium blood levels of COPD patients with respiratory muscle dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 163s Year: 2006 Usefulness of GDF-15 as a biomarker of respiratory worsening in COVID-19 patients. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Determination of levels of markers of systemic inflammation in patients with chronic bronchitis in combination with concomitant gastroesophageal reflux disease Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018